Skip to main content
Bloomberg

Astra Buying Bristol Makes No Sense, Fazeli Says

By
Watch on Grafa TV

AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense.